{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:28:13Z","timestamp":1781220493569,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,3]]},"DOI":"10.7759\/cureus.57535","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T15:14:48Z","timestamp":1712157288000},"source":"Crossref","is-referenced-by-count":3,"title":["Hyponatremia With Anticonvulsant Medications: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Kristin Nicole","family":"Bembenick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibin","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Siddaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.11176","article-title":"Diagnosis and management of hyponatremia: a review","volume":"328","author":"Adrogu\u00e9 HJ","year":"2022","unstructured":"Adrogu\u00e9 HJ, Tucker BM, Madias NE. Diagnosis and management of hyponatremia: a review. JAMA. 2022, 328:280-91. 10.1001\/jama.2022.11176","journal-title":"JAMA"},{"key":"ref2","unstructured":"Prevalence and risk factors for hyponatremia in adult epilepsy patients. large-scale cross-sectional cohort study. (2023). Accessed: Feb 26: https:\/\/www.clinicalkey.com\/."},{"key":"ref3","article-title":"Varying uses of anticonvulsant medications","volume":"5","author":"Cascade E","year":"2008","unstructured":"Cascade E, Kalali AH, Weisler RH. Varying uses of anticonvulsant medications. Psychiatry (Edgmont). 2008, 5:31-3.","journal-title":"Psychiatry (Edgmont)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001104","article-title":"Update on anti seizure medications","volume":"28","author":"Abou-Khalil BW","year":"2022","unstructured":"Abou-Khalil BW. Update on anti seizure medications. Continuum (Minneap Minn). 2022, 28:500-35. 10.1212\/CON.0000000000001104","journal-title":"Continuum (Minneap Minn)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s1059-1311(95)80003-4","article-title":"Mechanisms of action of antiepileptic drugs","volume":"4","author":"Davies JA","year":"1995","unstructured":"Davies JA. Mechanisms of action of antiepileptic drugs. Seizure. 1995, 4:267-71. 10.1016\/s1059-1311(95)80003-4","journal-title":"Seizure"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-33046","article-title":"Some common issues in the use of antiepileptic drugs","volume":"22","author":"Asconap\u00e9 JJ","year":"2002","unstructured":"Asconap\u00e9 JJ. Some common issues in the use of antiepileptic drugs. Semin Neurol. 2002, 22:27-39. 10.1055\/s-2002-33046","journal-title":"Semin Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195810","article-title":"Pathophysiology of drug-induced hyponatremia","volume":"11","author":"Kim GH","year":"2022","unstructured":"Kim GH. Pathophysiology of drug-induced hyponatremia. J Clin Med. 2022, 11:5810. 10.3390\/jcm11195810","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6125.1445","article-title":"Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine","volume":"1","author":"Stephens WP","year":"1978","unstructured":"Stephens WP, Coe JY, Baylis PH. Plasma arginine vasopressin concentrations and antidiuretic action of carbamazepine. Br Med J. 1978, 1:1445-7. 10.1136\/bmj.1.6125.1445","journal-title":"Br Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016101139","article-title":"Diagnosis and treatment of hyponatremia: compilation of the guidelines","volume":"28","author":"Hoorn EJ","year":"2017","unstructured":"Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. J Am Soc Nephrol. 2017, 28:1340-9. 10.1681\/ASN.2016101139","journal-title":"J Am Soc Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12268","article-title":"Brief history of anti-seizure drug development","volume":"3","author":"Rho JM","year":"2018","unstructured":"Rho JM, White HS. Brief history of anti-seizure drug development. Epilepsia Open. 2018, 3:114-9. 10.1002\/epi4.12268","journal-title":"Epilepsia Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4102\/phcfm.v12i1.2162","article-title":"General side effects and challenges associated with anti-epilepsy medication: a review of related literature","volume":"12","author":"Mutanana N","year":"2020","unstructured":"Mutanana N, Tsvere M, Chiweshe MK. General side effects and challenges associated with anti-epilepsy medication: a review of related literature. Afr J Prim Health Care Fam Med. 2020, 12:e1-5. 10.4102\/phcfm.v12i1.2162","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.0258","article-title":"Risk of major congenital malformations and exposure to antiseizure medication monotherapy","author":"Battino D","year":"2024","unstructured":"Battino D, Tomson T, Bonizzoni E, et al.. Risk of major congenital malformations and exposure to antiseizure medication monotherapy. JAMA Neurol. 2024, 10.1001\/jamaneurol.2024.0258","journal-title":"JAMA Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1248399","article-title":"Hyponatremia induced by antiepileptic drugs in patients with epilepsy","volume":"16","author":"Lu X","year":"2017","unstructured":"Lu X, Wang X. Hyponatremia induced by antiepileptic drugs in patients with epilepsy. Expert Opin Drug Saf. 2017, 16:77-87. 10.1080\/14740338.2017.1248399","journal-title":"Expert Opin Drug Saf"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.03.005","article-title":"Hyponatremia following esclicarbazepine therapy","volume":"29","author":"Gupta DK","year":"2015","unstructured":"Gupta DK, Bhoi SK, Kalita J, Misra UK. Hyponatremia following esclicarbazepine therapy. Seizure. 2015, 29:11-4. 10.1016\/j.seizure.2015.03.005","journal-title":"Seizure"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2019.03.018","article-title":"Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures","volume":"153","author":"Chung S","year":"2019","unstructured":"Chung S, Sinha SR, Shah A, et al.. Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures. Epilepsy Res. 2019, 153:59-65. 10.1016\/j.eplepsyres.2019.03.018","journal-title":"Epilepsy Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13593","article-title":"Antiepileptic drugs and hyponatremia in older adults: two population-based cohort studies","volume":"57","author":"Gandhi S","year":"2016","unstructured":"Gandhi S, McArthur E, Mamdani MM, et al.. Antiepileptic drugs and hyponatremia in older adults: two population-based cohort studies. Epilepsia. 2016, 57:2067-79. 10.1111\/epi.13593","journal-title":"Epilepsia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/096032718900800501","article-title":"Hyponatraemia during oxcarbazepine therapy","volume":"8","author":"Pendlebury SC","year":"1989","unstructured":"Pendlebury SC, Moses DK, Eadie MJ. Hyponatraemia during oxcarbazepine therapy. Hum Toxicol. 1989, 8:337-44. 10.1177\/096032718900800501","journal-title":"Hum Toxicol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(87)90025-8","article-title":"Hyponatremia induced by oxcarbazepine","volume":"1","author":"Johannessen AC","year":"1987","unstructured":"Johannessen AC, Nielsen OA. Hyponatremia induced by oxcarbazepine. Epilepsy Res. 1987, 1:155-6. 10.1016\/0920-1211(87)90025-8","journal-title":"Epilepsy Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1993.tb04106.x","article-title":"Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment","volume":"87","author":"Friis ML","year":"1993","unstructured":"Friis ML, Kristensen O, Boas J, et al.. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment. Acta Neurol Scand. 1993, 87:224-7. 10.1111\/j.1600-0404.1993.tb04106.x","journal-title":"Acta Neurol Scand"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000188819.45330.90","article-title":"Hyponatremia from oxcarbazepine and carbamazepine","volume":"65","author":"Dong X","year":"2005","unstructured":"Dong X, Leppik IE, White J, Rarick J. Hyponatremia from oxcarbazepine and carbamazepine. Neurology. 2005, 65:1976-8. 10.1212\/01.wnl.0000188819.45330.90","journal-title":"Neurology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13069","article-title":"Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia","volume":"23","author":"Berghuis B","year":"2016","unstructured":"Berghuis B, de Haan GJ, van den Broek MP, Sander JW, Lindhout D, Koeleman BP. Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia. Eur J Neurol. 2016, 23:1393-9. 10.1111\/ene.13069","journal-title":"Eur J Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2018.03.023","article-title":"Antiepileptic drugs-induced hyponatremia: review and analysis of 560 hospitalized patients","volume":"143","author":"Intravooth T","year":"2018","unstructured":"Intravooth T, Staack AM, Juerges K, Stockinger J, Steinhoff BJ. Antiepileptic drugs-induced hyponatremia: review and analysis of 560 hospitalized patients. Epilepsy Res. 2018, 143:7-10. 10.1016\/j.eplepsyres.2018.03.023","journal-title":"Epilepsy Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.43.6.540","article-title":"Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction","volume":"43","author":"Perucca E","year":"1980","unstructured":"Perucca E, Richens A. Reversal by phenytoin of carbamazepine-induced water intoxication: a pharmacokinetic interaction. J Neurol Neurosurg Psychiatry. 1980, 43:540-5. 10.1136\/jnnp.43.6.540","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2005.64004.x","article-title":"Hyponatremia associated with repeated use of levetiracetam","volume":"46","author":"Nasrallah K","year":"2005","unstructured":"Nasrallah K, Silver B. Hyponatremia associated with repeated use of levetiracetam. Epilepsia. 2005, 46:972-3. 10.1111\/j.1528-1167.2005.64004.x","journal-title":"Epilepsia"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-017-0825-4","article-title":"Levetiracetam-induced hyponatremia","volume":"118","author":"Rosca EC","year":"2018","unstructured":"Rosca EC, Simu M. Levetiracetam-induced hyponatremia. Acta Neurol Belg. 2018, 118:123-4. 10.1007\/s13760-017-0825-4","journal-title":"Acta Neurol Belg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042743","article-title":"Nephrogenic syndrome of inappropriate antidiuresis","volume":"352","author":"Feldman BJ","year":"2005","unstructured":"Feldman BJ, Rosenthal SM, Vargas GA, et al.. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med. 2005, 352:1884-90. 10.1056\/NEJMoa042743","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10190","article-title":"Effects of oxcarbazepine on sodium concentration and water handling","volume":"51","author":"Sachdeo RC","year":"2002","unstructured":"Sachdeo RC, Wasserstein A, Mesenbrink PJ, D'Souza J. Effects of oxcarbazepine on sodium concentration and water handling. Ann Neurol. 2002, 51:613-20. 10.1002\/ana.10190","journal-title":"Ann Neurol"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfq317","article-title":"Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression","volume":"25","author":"de Bragan\u00e7a AC","year":"2010","unstructured":"de Bragan\u00e7a AC, Moyses ZP, Magaldi AJ. Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression. Nephrol Dial Transplant. 2010, 25:3840-5.","journal-title":"Nephrol Dial Transplant"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-017-0295-9","article-title":"A case of nephrogenic syndrome of inappropriate antidiuresis caused by carbamazepine","volume":"7","author":"Sekiya N","year":"2018","unstructured":"Sekiya N, Awazu M. A case of nephrogenic syndrome of inappropriate antidiuresis caused by carbamazepine. CEN Case Rep. 2018, 7:66-8. 10.1007\/s13730-017-0295-9","journal-title":"CEN Case Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2013.11.015","article-title":"Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia","volume":"23","author":"Kim YS","year":"2014","unstructured":"Kim YS, Kim DW, Jung KH, et al.. Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia. Seizure. 2014, 23:208-12. 10.1016\/j.seizure.2013.11.015","journal-title":"Seizure"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2019.10.013","article-title":"Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study","volume":"73","author":"Yamamoto Y","year":"2019","unstructured":"Yamamoto Y, Takahashi Y, Imai K, Ohta A, Kagawa Y, Inoue Y. Prevalence and risk factors for hyponatremia in adult epilepsy patients: Large-scale cross-sectional cohort study. Seizure. 2019, 73:26-30. 10.1016\/j.seizure.2019.10.013","journal-title":"Seizure"},{"key":"ref32","article-title":"Gender differences of sodium metabolism and hyponatremia as an adverse drug effect","volume":"40","author":"Grikiniene J","year":"2004","unstructured":"Grikiniene J, Volbekas V, Stakisaitis D. Gender differences of sodium metabolism and hyponatremia as an adverse drug effect. Medicina (Kaunas). 2004, 40:935-42.","journal-title":"Medicina (Kaunas)"},{"key":"ref33","article-title":"Hyponatremia","author":"Rondon H","year":"2024","unstructured":"Rondon H, Badireddy M. . Hyponatremia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.04.025","article-title":"Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: a population-based case-control study","volume":"59","author":"Falhammar H","year":"2018","unstructured":"Falhammar H, Lindh JD, Calissendorff J, Farmand S, Skov J, Nathanson D, Mannheimer B. Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: a population-based case-control study. Seizure. 2018, 59:28-33. 10.1016\/j.seizure.2018.04.025","journal-title":"Seizure"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58050559","article-title":"Oxcarbazepine and Hyponatremia","volume":"58","author":"\u010ciau\u0161kait\u0117 J","year":"2022","unstructured":"\u010ciau\u0161kait\u0117 J, Gel\u017einien\u0117 G, Jurkevi\u010dien\u0117 G. Oxcarbazepine and Hyponatremia. Medicina (Kaunas). 2022, 58:559. 10.3390\/medicina58050559","journal-title":"Medicina (Kaunas)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18721","article-title":"Incidence trends and risk factors for hyponatremia in epilepsy patients: a large-scale real-world data study","volume":"9","author":"Yamamoto Y","year":"2023","unstructured":"Yamamoto Y, Ohta A, Usui N, Imai K, Kagawa Y, Takahashi Y. Incidence trends and risk factors for hyponatremia in epilepsy patients: a large-scale real-world data study. Heliyon. 2023, 9:e18721. 10.1016\/j.heliyon.2023.e18721","journal-title":"Heliyon"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.09.026","article-title":"Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits","volume":"119","author":"Renneboog B","year":"2006","unstructured":"Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006, 119:10.1016\/j.amjmed.2005.09.026","journal-title":"Am J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.06120809","article-title":"Hyponatremia independent of osteoporosis is associated with fracture occurrence","volume":"5","author":"Kinsella S","year":"2010","unstructured":"Kinsella S, Moran S, Sullivan MO, Molloy MG, Eustace JA. Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol. 2010, 5:275-80. 10.2215\/CJN.06120809","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/epi.16828","article-title":"Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy","volume":"62","author":"Berghuis B","year":"2021","unstructured":"Berghuis B, Hulst J, Sonsma A, et al.. Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. Epilepsia. 2021, 62:778-84. 10.1111\/epi.16828","journal-title":"Epilepsia"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13022","article-title":"Impact of chronic hyponatremia on neurocognitive and neuromuscular function","volume":"48","author":"Refardt J","year":"2018","unstructured":"Refardt J, Kling B, Krausert K, Fassnacht M, von Felten S, Christ-Crain M, Fenske W. Impact of chronic hyponatremia on neurocognitive and neuromuscular function. Eur J Clin Invest. 2018, 48:e13022. 10.1111\/eci.13022","journal-title":"Eur J Clin Invest"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2023.21.2.61","article-title":"Osmotic demyelination syndrome in a high-risk patient despite cautious correction of hyponatremia","volume":"21","author":"Hwang C","year":"2023","unstructured":"Hwang C. Osmotic demyelination syndrome in a high-risk patient despite cautious correction of hyponatremia. Electrolyte Blood Press. 2023, 21:61-5. 10.5049\/EBP.2023.21.2.61","journal-title":"Electrolyte Blood Press"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/223822-hyponatremia-with-anticonvulsant-medications-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T15:14:56Z","timestamp":1712157296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/223822-hyponatremia-with-anticonvulsant-medications-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.57535","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,3]]}}}